Recall StatusTerminated
Date Initiated2004-09-01
Date Terminated2004-11-30
Product Quantity22,442 cartons
Reason for Recall
The XSYSTEMS Dilution Buffer when used with TDx/TDxFLx Benzodiazepines assay can cause shifts in control values and patient results.
Firm Action
Abbott sent Device Correction letters dated 9/1/04 to all customers receiving the TDx/TDxFLx Benzodiazepines assay, list 9674, informing them of the shift in control values and patient results when used with the XSYSTEMS Dilution Buffer, list 9519-02. The letter gave examples of the effects observed in the benzodiazepines assay performance, and listed the following actions to be taken until Abbott completes their investigation:
* During the use of a single lot of buffer, recalibrate the TDx/TDxFLx Benzodiazepines assay every 14 days.
* Perform a new calibration run on the TDx/TDxFLx Benzodiazepines assay when a new lot number of XSYSTEMS Dilution Buffer is used.
* These actions are in addition to the package insert calibration and quality control requirements.
* Follow your laboratory procedures for notification of the health care providers that you serve.
Any questions were directed to Abbott''s Customer Service at 1-877-4ABBOTT.
Distribution Pattern
Nationwide and internationally to Argentina, Australia, Brazil, Chile, Colombia, Costa Rica, El Salvador, Germany, Guatemala, Honduras, Hong Kong, Mexico, Panama, Peru, Puerto Rico, Singapore, South Korea, Taiwan, Thailand, the United Kingdom, Uruguay and Venezuela
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.